After $270M round, BioNTech pens TCR pact with Scancell by Nick Paul Taylor Tuesday, January 9, 2018 BioNTech will work with Scancell to discover and characterize T cell receptors and has an option to form a license agreement for the therapeutics.
EuroBiotech: More Articles of Note by Nick Paul Taylor Thursday, May 11, 2017 In our EuroBiotech roundup this week, Ipsen rejigs R&D operation, Pierre Fabre posts positive phase 3 data and Immunocore, GSK pact advances.
Scancell taps lung cancer nonprofit for trial recruitment by Phil Taylor Monday, January 30, 2017 Scancell is taking no chances when it comes to carrying out trials of its candidate vaccine for non-small cell lung cancer.
